Table 4.
Association between survival status and SAA or PON-1 activity in patients with SARS-CoV2 infection.
Outcome | Survival Status | Univariate Model | Adjusted Model | ||
---|---|---|---|---|---|
Mean (95% CI) | p-Value | Mean (95% CI) | p-Value | ||
SAA (ng/mL) |
Death | 60.1 (44.2; 81.7) |
0.8616 | 64.3 (37.8; 109.3) |
0.9530 |
Alive | 58.3 (49.8; 68.3) |
63.4 (40.2; 99.9) |
|||
PON-1 activity (µU/mL) |
Death | 1512.1 (1237.5; 1847.6) | 0.6523 | 1687.4 (1340.2; 2124.4) |
0.5480 |
Alive | 1592.5 (1436.4; 1765.5) | 1558.0 (1398.5; 1735.6) |
Data are expressed as geometric means and 95% CI. Data are adjusted for age, gender, BMI, smoking, and antihypertensive medications (the latter only for SAA). SAA, Serum amyloid A; PON-1, paraoxonase-1.